Downstream Processing

Fouling Mechanisms of Filters in the Harvest Development of Monoclonal Antibody Therapeutics—Pt 2

The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.

Fouling Mechanisms of Filters in the Harvest Development of Monoclonal Antibody Therapeutics—Pt 1

The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters.

Stepping Up Process Control with Single-Use Systems

SUS aids biopharma manufacturers to overcome the rigidity of more traditional stainless-steel technologies.

Please check back later for more content.

Downstream Processing

Fouling Mechanisms of Filters in the Harvest Development of Monoclonal Antibody Therapeutics—Pt 2

Fouling Mechanisms of Filters in the Harvest Development of Monoclonal Antibody Therapeutics—Pt 1

Stepping Up Process Control with Single-Use Systems

Trending on BioPharm International

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress